h1

001007304 001__ 1007304
001007304 005__ 20250509050352.0
001007304 0247_ $$2HSB$$aeva571897
001007304 0247_ $$2ISSN$$a1522-8517
001007304 0247_ $$2ISSN$$a1523-5866
001007304 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85208549575
001007304 0247_ $$2WOS$$aWOS:001263250000001
001007304 0247_ $$2doi$$a10.1093/neuonc/noae078
001007304 0247_ $$2pmid$$apmid:38970818
001007304 037__ $$aRWTH-CONV-253658
001007304 041__ $$aEnglish
001007304 1001_ $$aGalldiks, Norbert$$b0$$eCorresponding author
001007304 245__ $$aPET imaging of gliomas: Status quo and quo vadis?$$honline, print
001007304 260__ $$aOxford$$bOxford Univ. Press$$c2024
001007304 3367_ $$00$$2EndNote$$aJournal Article
001007304 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001007304 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book
001007304 3367_ $$2BibTeX$$aARTICLE
001007304 3367_ $$2DRIVER$$aarticle
001007304 3367_ $$2DataCite$$aOutput Types/Journal article
001007304 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001007304 591__ $$aDenmark
001007304 591__ $$aGermany
001007304 7001_ $$0P:(DE-82)120979$$aLohmann, Philipp$$b1$$urwth
001007304 7001_ $$aFriedrich, Michel$$b2
001007304 7001_ $$aWerner, Jan-Michael$$b3
001007304 7001_ $$aStetter, Isabelle$$b4
001007304 7001_ $$aWollring, Michael M.$$b5
001007304 7001_ $$aCeccon, Garry$$b6
001007304 7001_ $$aStegmayr, Carina$$b7
001007304 7001_ $$aKrause, Sandra$$b8
001007304 7001_ $$aFink, Gereon R.$$b9
001007304 7001_ $$aLaw, Ian$$b10
001007304 7001_ $$0P:(DE-82)013919$$aLangen, Karl-Josef$$b11$$urwth
001007304 7001_ $$aTonn, Joerg-Christian$$b12
001007304 770__ $$aTheranostics in CNS Tumors
001007304 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noae078$$n9$$pS185-S198$$tNeuro-Oncology : official journal of the World Federation of Neuro-Oncology$$v26$$x1523-5866
001007304 909CO $$ooai:publications.rwth-aachen.de:1007304$$pVDB
001007304 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)120979$$aRWTH Aachen$$b1$$kRWTH
001007304 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)013919$$aRWTH Aachen$$b11$$kRWTH
001007304 9141_ $$y2024
001007304 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
001007304 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2022$$d2024-12-11
001007304 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
001007304 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
001007304 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
001007304 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
001007304 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
001007304 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
001007304 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-11$$wger
001007304 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-11
001007304 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bNEURO-ONCOLOGY : 2022$$d2024-12-11
001007304 9201_ $$0I:(DE-82)532500-2_20140620$$k532500-2$$lKlinik und Lehrstuhl für Nuklearmedizin$$x0
001007304 9201_ $$0I:(DE-82)532500-3_20140620$$k532500-3$$lLehr- und Forschungsgebiet Experimentelle und klinische Nuklearmedizin (FZ Jülich)$$x1
001007304 961__ $$z2025-03-20
001007304 970__ $$aeva571897
001007304 980__ $$aI:(DE-82)532500-2_20140620
001007304 980__ $$aI:(DE-82)532500-3_20140620
001007304 980__ $$aUNRESTRICTED
001007304 980__ $$aVDB
001007304 980__ $$acontb
001007304 980__ $$ajournal